C

Cycle Pharmaceuticals

Repurposes drugs for rare diseases

Medical Associate Director - Clinical Development

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, UK

About the Job

Requirements

  • A medical degree (MBBS, MBChB or equivalent) and full General Medical Council registration, or eligibility for registration.
  • Significant pharmaceutical or biotechnology industry experience in clinical development, including medical monitoring or medical leadership of Phase 2 and/or Phase 3 studies.
  • Experience in rare disease clinical development.
  • Direct experience of Food and Drug Administration interactions, such as Type B or end-of-Phase 2 meetings.
  • Experience designing studies in small populations, including novel endpoints, natural history comparisons or adaptive designs.
  • Sound knowledge of International Council for Harmonisation Good Clinical Practice and relevant ICH guidelines, including E4, E6, E8, E9 and E11.
  • Strong scientific and clinical judgement, including the ability to make decisions under uncertainty and communicate them clearly to technical and non-technical audiences.
  • Written and verbal communication skills, including the ability to influence across disciplines without direct authority.
  • Willingness to travel, including to the United States.

Responsibilities

  • Lead the clinical development strategy for assigned programmes, translating target product profiles into integrated development plans and defining clinically meaningful, feasible study objectives, populations and endpoints for rare disease populations.
  • Work with Regulatory Affairs on clinical and regulatory strategy, including endpoints, natural history data and external control approaches; act as clinical lead in Food and Drug Administration meetings and author or review clinical content for regulatory submissions and briefing packages.
  • Own the medical and scientific content of clinical protocols, amendments, statistical analysis plan inputs and informed consent materials, integrating nonclinical and translational evidence into dose selection and patient eligibility decisions.
  • Lead scientific engagement with investigators, clinical experts, advisory boards and steering committees, and oversee clinical outcome assessment and patient-reported outcome strategies with external experts and patient advocacy groups.
  • Lead clinical pharmacology across assigned programmes, including dose and regimen selection, exposure–response analysis, dose justification for pivotal studies, and paediatric dose selection and extrapolation.
  • Design and interpret clinical pharmacology studies, including bioavailability, bioequivalence, food effect, drug–drug interaction and special population studies; oversee population pharmacokinetics, pharmacokinetic/pharmacodynamic and physiologically based modelling, and define bridging strategies for reformulation programmes.
  • Act as sponsor medical lead for assigned studies, oversee contract research organization medical monitors, respond to medical queries and review clinical data for eligibility, medically significant protocol deviations, and emerging safety and efficacy trends.
  • Partner with Pharmacovigilance on serious adverse events, safety signal evaluation and reporting; support data monitoring committees.
  • Contribute to publications and congress presentations, maintain awareness of evolving Food and Drug Administration, European Medicines Agency and International Council for Harmonisation guidance, and drive the development and implementation of clinical development procedures and standards.
  • Contribute to departmental budgeting, resource planning and prioritisation.

Desired Qualifications

  • Clinical training in a relevant specialty, such as metabolic medicine, paediatrics, neurology or clinical pharmacology.
  • Experience in clinical pharmacology, including dose selection, pharmacokinetic/pharmacodynamic interpretation and the design of clinical pharmacology studies.

About the Company

Cycle Pharmaceuticals

Repurposes drugs for rare diseases

Cycle Pharmaceuticals develops and sells medicines that improve existing drugs for rare genetic diseases. It focuses on repurposing, reformulating, and reintroducing generic medications to treat rare metabolic, immunological, and neurological conditions (such as HT-1, PKU, MS). Its products are delivered as ready-to-use therapies in the United States, aided by the Cycle Vita patient support program that helps with education, insurance coordination, and affordability to ensure patients can stay on treatment. Unlike some peers that chase new molecular entities, Cycle builds value by optimizing existing drugs to fit patient needs, aiming for reliable cash flow, profitability, and the ability to fund acquisitions and growth. The company also operates a social mission to provide free medicines in developing countries. Overall, its goal is to improve quality of life for people with rare diseases while expanding access and maintaining sustainable operations.

Company size
201-500
Company stage
Debt Financing
Total funding
$25M
Headquarters
Cambridge, United Kingdom
Founded
2012

Recently Posted Jobs

Explore more opportunities at Cycle Pharmaceuticals

See more jobs